University of Miami Law Review
Volume 73
Number 1 Fall 2018

Article 8

10-30-2018

Mitochondrial Replacement Therapy: How a Government for the
People, Failed the People
Jeffery Mark Sauer

Follow this and additional works at: https://repository.law.miami.edu/umlr
Part of the Health Law and Policy Commons, and the Science and Technology Law Commons

Recommended Citation
Jeffery Mark Sauer, Mitochondrial Replacement Therapy: How a Government for the People, Failed the
People, 73 U. Miami L. Rev. 300 (2018)
Available at: https://repository.law.miami.edu/umlr/vol73/iss1/8

This Note is brought to you for free and open access by the Journals at University of Miami School of Law
Institutional Repository. It has been accepted for inclusion in University of Miami Law Review by an authorized
editor of University of Miami School of Law Institutional Repository. For more information, please contact
library@law.miami.edu.

NOTES
Mitochondrial Replacement Therapy:
How a Government for the People, Failed
the People
JEFFERY MARK SAUER*

Despite having the potential to significantly reduce the
passage of many lethal diseases and devastating birth defects, mitochondrial replacement therapy—a controversial
medical procedure in which mitochondrial RNA from a
healthy female replaces the mitochondrial RNA from the intended mother in vitro—will have no place in the United
States anytime soon. Under the guise of purported safety
concerns and ethical dilemmas, the Republican Congress
used its “power of the purse” to halt any and all research
furthering mitochondrial replacement therapy, notwithstanding the fact that many leaders in the medical community have advocated for further research. Several developed
countries have already implemented limited applications of
the procedure. However, as long as Congress continues to
abuse its constitutional appropriations power in a manner
inconsistent with the original intent of the framers, policies
that can greatly benefit society as a whole will be sacrificed
in the name of partisanship and narrow-mindedness.
*
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INTRODUCTION
“We are on the cusp of being able to do [gene editing] safely,
and the prospect of telling a parent that they won’t have access to these therapies is morally untenable . . . A ban doesn’t
make sense . . . .”1
Leo Chapman-Nesseth was born June 6, 2009 in Minnesota.2
Described by his parents Andrew and Lindsay as “perfectly normal
and healthy through the first six months of his life,” Leo exhibited
many of the conventional characteristics of a newborn: a pinkish
color, ten fingers, ten toes, and a rambunctious personality.3 At just
eleven months old, Leo was diagnosed with Alpers’ disease,4 an autosomal recessive disease caused by a mutation in mitochondrial
DNA with no cure and no method to slow its progression. 5 Leo
quickly began to experience symptoms such as seizures and liver
failure.6 He died just three days after celebrating his first birthday.7
“Each year, 1,000 to 4,000 children in the United States are born
with a mitochondrial disease.”8 Hope may be on the horizon, however, as doctors and researchers now believe that it may be possible
to prevent the passage of mutated mitochondrial DNA from mothers
to their offspring via a controversial technique still in the early
1

Alex Pearlman, Scientists Argue the US Ban on Human Gene Editing Will
Leave It Behind, MOTHERBOARD (Aug. 4, 2016, 2:00 PM), https://motherboard.
vice.com/en_us/article/nz7dp8/scientists-argue-the-us-ban-on-human-gene-editing-will-leave-it-behind (quoting bioethicist James Hughes, Executive Director of
the Institute for Ethics and Emerging Technologies).
2
Daily Globe News, Family Raises Awareness for Rare Disease, GLOBE
(July 1, 2010, 9:49 PM), http://www.dglobe.com/news/1372692-family-raisesawareness-rare-disease.
3
Id.
4
Id.; Alpers’ Disease Information Page, NAT’L INST. NEUROLOGICAL DISORDERS & STROKE, https://www.ninds.nih.gov/Disorders/All-Disorders/Al persDisease-Information-Page (last modified June 15, 2018).
5
Alpers’ Disease Information Page, supra note 4.
6
Nidhi Subbaraman, ‘3-Parent Babies’ Could Eliminate Rare Diseases, but
US Lawmakers Have Blocked the Technology, BUZZFEED NEWS (Sept. 13, 2016,
9:02 AM), https://www.buzzfeed.com/nidhisubbaraman/mitochondrial-diseasecongress?utm_term=.hcAjPeqYqW#.vpYrQ9YRYj.
7
Id.
8
Frequently Asked Questions, UNITED MITOCHONDRIAL DISEASE FOUND.,
http://www.umdf.org/faq-page-1/ (last visited Sept. 14, 2018).

2018]

HOW A GOVERNMENT FOR THE PEOPLE, FAILED THE PEOPLE

303

stages of experimentation. This process is known as mitochondrial
replacement therapy.9 Despite the safety concerns10 associated with
any groundbreaking medical procedure, as well as the ethical dilemma that germline-modified offspring from three parents presents,11 an expert panel of scientists and bioethicists from the National Academies of Sciences and Institute of Medicine concluded
that it was ethically permissible to “go forward, but with caution”
with limited experimentation of mitochondrial replacement techniques at this point.12
Unfortunately, any momentum that had progressed in transitioning towards human trials in mitochondrial replacement therapy was
abruptly halted by Section 749 of the Consolidated Appropriation
Act of 2016, which precludes the Food and Drug Administration
(“FDA”) from evaluating any “research in which a human embryo
is intentionally created or modified to include a heritable genetic
modification.” 13 In short, the largely Republican 14 Congress precluded the FDA from pursuing what could be a potentially life-saving technology for future generations.15 It will now be seemingly
9

Eli Y. Adashi & Glenn Cohen, Mitochondrial Replacement Therapy: Unmade in the USA, 317 JAMA 574, 574–75 (2017), https://jamanetwork.com/ journals/jama/fullarticle/2601488.
10
Id. at 574 (noting that safety concerns surrounding mitochondrial replacement therapy include possible mismatches between donors and recipients of Mitochondrial DNA, as well as the possibility that some of the mutated Mitochondrial DNA at issue may be transferred which would result in disease as well).
11
Id. at 575.
12
Joel Achenbach, Ethicists Approve ‘3 Parent’ Embryos to Stop Diseases,
but Congressional Ban Remains, WASH. POST (Feb. 3, 2016), https://www.washingtonpost.com/news/speaking-of-science/wp/2016/02/03/to-prevent-diseaseethicists-approve-creation-of-embryos-with-three-genetic-parents/?utm_term
=.ccc4a92b133e (quoting chairman Jeffrey Kahn, bioethicist at John Hopkins
University); see INST. OF MED., THE NAT’L ACADEMIES OF SCI., ENG’G & MED.,
REPORT IN BRIEF OF MITOCHONDRIAL REPLACEMENT TECHNIQUES: ETHICAL, SOCIAL, AND POLICY CONSIDERATIONS (2016), http://www.nationalacademies.org
/hmd/~/media/Files/Report%20Files/2016/Mitochondrial%20Replacement%20Techniques/MitoEthics-RIB.pdf.
13
Consolidated Appropriations Act, 2016, Pub. L. 114-113, § 749, 129 Stat.
2242, 2283 (2015).
14
2016 House Election Live Results, 270TOWIN, https://www.270towin.com
/2016-house-election-results-live/ (last visited Sept. 15, 2018) (showing House
election results and Senate election results in 2016).
15
Adashi & Cohen, supra note 9, at 574–75.
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impossible for the FDA to eventually make a definitive ruling on the
safety and efficacy of the procedure.16 To muddy the waters even
further, the congressional record is completely silent on the identity
of the supporters of the ban, and the exact motives for including the
ban in the budget bill remain uncertain.17
This Note will first outline exactly what mitochondrial replacement therapy is and what experimentation of this technique entails.
Part II will discuss the history and purpose of the Constitution’s Appropriations Clause, demonstrating its clear potential for abuse and
potential violation of the separation of powers doctrine. Part III will
then illustrate historical Republican opposition and hostility towards
disruptions with the natural birth cycle in support of my hypothesis,
beginning with abortion and continuing with in vitro fertilization
(“IVF”) and stem-cell research. Part IV will then provide a recommended resolution between the FDA and Congress upon renewal of
the budget bill in 2018.
I. MITOCHONDRIAL DISEASE: THE DIAGNOSIS, THE TREATMENT,
AND THE IMPLICATIONS
A. What Is Mitochondrial Disease and Whom Does It Affect?
Mitochondria are organelles that are responsible for producing
energy within cells in order for the cells to function properly.18 Mitochondria also contain a small amount of genetic material—their
own DNA—distinct from the DNA that is ordinarily found in a
cell’s nucleus.19 Mitochondrial DNA is thus passed down from a
mother to her child, and any mutations that occur in the mitochondrial genome can in turn lead to a plethora of mitochondrial diseases

16

Achenbach, supra note 12.
Adashi & Cohen, supra note 9, at 574–75.
18
Mike Orcutt, The Unintended Consequence of Congress’s Ban on Designer
Babies, MIT TECH. REV. (Aug. 26, 2016), https://www.technologyreview.com
/s/602219/the-unintended-consequence-of-congresss-ban-on-designer-babies/#c
omments.
19
Id.; see also Advisory on Legal Restrictions on the Use of Mitochondrial
Replacement Techniques to Introduce Donor Mitochondria into Reproductive
Cells Intended for Transfer into a Human Recipient, U.S. FOOD & DRUG ADMIN.,
https://www.fda.gov/biologicsbloodvaccines/cellulargenetherapyproducts/ucm
570185.htm (last updated Mar. 16, 2018) [hereinafter Advisory].
17
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ranging in severity from relatively mild to potentially life-threatening.20 Because mitochondria are the primary sources of energy production for all cells in the body, mitochondrial diseases typically
manifest in tissues that rely heavily on energy production, including
brain, heart, muscle, pancreas, and kidney cells.21 As many as 4,000
children are born with mitochondrial diseases in the United States
every year, and there are no licensed cures or treatments for these
debilitating diseases.22
B. How Can Mitochondrial Replacement Therapy Prevent Mitochondrial Disease?
Although mitochondrial disorders are believed to be incurable
per se, researchers now believe that it may be possible to prevent
them from occurring at all through mitochondrial replacement therapy.23 Mitochondrial replacement therapy is the “combining [of] the
nucleus from the egg of an affected woman with the cytoplasm from
an unaffected woman that contains healthy mitochondria.”24
Dr. Shoukhrat Mitalipov, Director of Oregon Health and Science
University’s Center for Embryonic Cell and Gene Therapy, has
demonstrated “in monkeys that a replacement mitochondrial genome from another mother can be effectively and safely passed to
offspring along with the nuclear DNA from the actual mother.”25
Mitalipov had been working closely with the FDA in order to develop future plans for human testing of mitochondrial replacement
therapy prior to the passage of the Consolidated Appropriation Act

20

See Gretchen Vogel, For Boys Only? Panel Endorses Mitochondrial Therapy, but Says Start with Male Embryos, SCI. (Feb. 3, 2016, 2:00 PM),
http://www.sciencemag.org/news/2016/02/boys-only-panel-endorses-mitochond
rial-therapy-says-start-male-embryos [hereinafter Vogel, For Boys Only?]
(“Males can’t pass along the mitochondrial DNA that is altered in the procedure . . . . Mitochondria] carry their own DNA, coding for 37 genes, which is
passed down from mother to child through the mitochondria in the egg cytoplasm.”) (emphasis added).
21
DANIELA BARBERY ET AL., SHOULD THE U.S. APPROVE MITOCHONDRIAL
REPLACEMENT THERAPY? 8 (2015).
22
Orcutt, supra note 18.
23
Adashi & Cohen, supra note 9, at 574.
24
Id.
25
Orcutt, supra note 18.
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of 2016.26 Mitalipov and his colleagues have also demonstrated that
this “three parent” approach through the use of IVF of human embryos is medically feasible.27
C. The Social and Ethical Concerns of Mitochondrial Replacement Therapy: How Do We Get There?
Although mitochondrial replacement therapy could one day
emerge as the exclusive method to allow women with mitochondrial
diseases to have healthy children, the experimental method is certainly not without social and ethical challenges. 28 Though it would
be a stretch to say doctors and scientists are, in fact, “play[ing]
God,”29 it is feasible to sympathize with those who are uncomfortable with the idea of scientists modifying human germlines. Some
fear mitochondrial replacement therapy may be the first step in one
day allowing a market for “designer babies” to flourish.30

26

Id.; see Consolidated Appropriations Act, 2016, Pub. L. 114-113, 129 Stat.
2242 (2015).
27
Orcutt, supra note 18.
28
See generally Ian Sample, ‘Three-Parent’ Babies Explained: What Are the
Concerns and Are They Justified?, GUARDIAN (Feb. 2, 2015, 10:56 AM), https://
www.theguardian.com/science/2015/feb/02/three-parent-babies-explained (discussing various ethical and religious objections scientists and others have raised
regarding the procedure).
29
John D. Loike & Nancy Reame, Opinion: Ethical Considerations of
“Three-Parent” Babies, SCIENTIST (Dec. 22, 2016), https://www.the-scientist.com/?articles.view/articleNo/47725/title/Opinion--Ethical-Consideratio nsof--Three-Parent--Babies/ (discussing the dilemma scientists researching mitochondrial replacement therapy face due to the popular belief that genetic modifications are akin to “play[ing] God”). Loike and Reame note, however, that “humans have engaged in genetic modifications of plants and animals for thousands
of years” without any ethical roadblocks, and are further engaged in a form of
genetic screening known as preimplantation genetic diagnosis (“PGD”), which
allows couples engaging in IVF to “screen” embryos for selection by eliminating
those that possess various genetic diseases. Id.
30
See Pam Belluck, Gene Editing for ‘Designer Babies’? Highly Unlikely,
Scientists Say, N.Y. TIMES (Aug. 4, 2017), https://www.nytimes.com/2017
/08/04/science/gene-editing-embryos-designer-babies.html. Belluck notes that
with modern-day science being one-step closer to repairing single gene mutations
and defects in order to bypass serious or even fatal diseases, it may mean that we
are also closer to “customizing” babies with “Lin-Manuel Miranda’s imagination
or Usain Bolt’s speed.” Id. This is misplaced for a variety of scientific reasons,
however, discussed in detail in the article. See id.
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Scientists in support of mitochondrial replacement therapy rebut
these assertions, however, by pointing out that mitochondrial replacement therapy is more akin to various forms of preventative
care, such as preimplantation genetic diagnosis of embryos to screen
for genetic diseases, as opposed to individual gene shopping.31 Furthermore, Philip Yeske, Science and Alliance Officer for the United
Mitochondrial Disease Foundation, points out that only a very narrow population—“women of childbearing age who have mitochondrial disorders and who want to have children”—stand to benefit
from the experimental technique in the first place; therefore, it is not
akin to making designer babies or selecting genetic traits.32
The unintended social and legal consequences that may stem
from “three-parent babies” are a second ethical roadblock for scientists and policymakers.33 The term “three-parent babies” has grown
to be frequently associated with mitochondrial replacement therapy
due to the nature of the procedure, which involves contributions
from three individuals: (1) the nucleus from the egg of an affected
mother, (2) the cytoplasm from an unaffected woman that contains
healthy mitochondria, and (3) the sperm of the father.34 Because the
nature of the procedure is seen as so fundamentally unconventional
compared to how the average couple would go about having a child,
it has led many to question how mitochondrial donation should be
regulated in regards to legal issues such as parental rights, as well as

31

See Sample, supra note 28 (emphasizing that a change in law to allow mitochondrial replacement therapy research to continue would not allow “designer
babies” to come about because the typical defining human characteristic traits
such as eye and hair color are controlled by DNA in the cell nucleus, not the cell’s
mitochondria).
32
Orcutt, supra note 18. Yeske notes that scientists researching mitochondrial replacement therapy “don’t feel it’s a slippery slope at all,” due to the narrow
target recipients of the procedure in the first place. Id.
33
See Sample, supra note 28 (note that the graphic entitled “[t]hree-person
embryos” outlines the two prominent mitochondrial replacement therapy techniques—maternal spindle transfer and pronuclear transfer—in which DNA from
three different individuals is utilized in the creation of the embryo).
34
See Adashi & Cohen, supra note 9, at 574; César Palacios-González, Mitochondrial Replacement Techniques: Egg Donation, Genealogy and Eugenics,
34 MONASH BIOETHICS REV. 37, 38 (2016).
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whether the resulting offspring have a legal right to know their true
lines of ancestry.35
This concern, although valid and well placed, is largely overblown for several reasons. First, from a practical standpoint, the mitochondrial DNA donation would come from an anonymous donor
who has no legal rights over the child and is not involved in the
child’s upbringing in any way.36 Therefore, as is the case with other
reproductive technologies involving third parties such as oocyte donation and gestational surrogacy, mitochondrial replacement therapy is likely capable of establishing similar legal methods that in
fact protect donor privacy. 37 From a strictly scientific standpoint,
this argument lacks muster as well because all 20,000 genes located
on the child’s twenty-three pairs of chromosomes would still come
from the child’s intended mother and father.38 The DNA contributed
by the donor woman, which sits in the mitochondria, would constitute less than 0.2% of the child’s DNA profile.39
II. THE BAN ON MITOCHONDRIAL REPLACEMENT THERAPY: HOW
CONGRESS HAS HELD THE FDA HOSTAGE THROUGH THE
APPROPRIATIONS CLAUSE
Although the benefits that mitochondrial replacement therapy
would have for women susceptible to passing along mitochondrial
diseases to their offspring are obvious, a congressional ban stands in
the way of anyone actually receiving these benefits. Congress disabled the FDA’s authority on the matter and swiftly put an end to all
35

See Loike & Reame, supra note 29. Loike proposes that because genetic
contributions from mitochondrial DNA of a donor is essential for the development
of the child, that genetic contribution from mitochondrial DNA should not be considered irrelevant to the status of parenthood, but should follow an already established avenue of determining or relinquishing parental rights, such as the system
in place for adoption. Id.
36
Sample, supra note 28.
37
Loike & Reame, supra note 29 (“Given its potential for permanent alterations of DNA, this technology should not be viewed as equivalent to classical
organ donation, but rather treated with precautions in line with other germline
interventions, such as egg or sperm donation, for which regulatory practices are
already in place. Using these as a framework, governments and the scientific community should invest time and money into making [mitochondrial replacement
therapy] widely available to patients.”).
38
See Sample, supra note 28.
39
Id.
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mitochondrial replacement therapy research in the United States
with nothing more than a ten-line provision in Section 749 of the
Consolidated Appropriations Act of 2016.40
Despite the United Kingdom’s approval in February 2015 of the
technology,41 the United States Congress was able to successfully
shut down this research notwithstanding much opposition and hostility from scientists, doctors, and patients throughout the country.42
As Dr. Shoukhrat Mitalipov has pointed out, despite the fact that the
United States was “one of the pioneers” in developing mitochondrial
replacement therapy, 43 clinical implementation of the procedure
will only take place in other countries such as the United Kingdom.44

40

Consolidated Appropriations Act, 2016, Pub. L. 114-113, § 749, 129 Stat.
2242, 2283 (2015).
41
See Ewen Callaway, Scientists Cheer Vote to Allow Three-Person Embryos, NATURE (Feb. 3, 2015), http://www.nature.com/news/scientists-cheervote-to-allow-three-person-embryos-1.16843 (noting that the United Kingdom’s
House of Commons vote to legalize mitochondrial replacement therapy by a vote
of 382 to 128 allows the United Kingdom to become the first country in the world
to allow clinical applications of mitochondrial replacement therapy).
42
See Subbaraman, supra note 6. Eli Adashi, Professor of Medical Science
at Brown University, described the ban as “something unusual, perhaps disturbing, about Congress laying down the law when the scientific community and public are just beginning to understand the issue.” Id. (emphasis added). Lindsay
Chapman, an advocate of mitochondrial replacement therapy after losing her son
Leo to Alpers’ Disease in 2010, has said that she “can’t even fathom why they
would think that that would be something we shouldn’t be researching and
frankly, doing clinical trials on . . . There’s just something inside of me that
screams at the idea that somebody else would stand in the way.” Id.; see supra
note 2 and accompanying text. Philip Yeske stated “[t]hey were very clear in their
report – they saw no ethical reason to limit human clinical studies for mitochondrial replacement therapy.” Subbaraman, supra note 6.
43
Id.
44
See Rosa J. Castro, Mitochondrial Replacement Therapy: The UK and US
Regulatory Landscapes, J.L. & BIOSCIENCES 726, 735 (2016), https://www.ncbi
.nlm.nih.gov/pmc/articles/PMC5570689/pdf/lsw051.pdf (“The different stances
of the UK and the USA with regard to MRT can probably be explained as the
result of a combination of (i) historical events, including the adverse reports from
cytoplasmic transfer treatments in the USA, (ii) the lack of a broader dialogue
with experts and the public, (iii) the lack of a specialized authority in charge of
reproductive technologies, and (iv) the deeply polarized abortion and ‘personhood’ debates.”).
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Congress was able to implement the ban effectively because the federal legislature potentially possesses the most powerful tool of any
of the three branches of government: the power of the purse.45
A. The Appropriations Clause: “The Power of the Purse”
The federal legislature’s appropriations power stems specifically from Article I, Section 9 of the Constitution. The Appropriations Clause states the following: “No Money shall be drawn from
the Treasury, but in Consequence of Appropriations made by Law;
and a regular Statement and Account of the Receipts and Expenditures of all public Money shall be published from time to time.”46 In
essence, for the executive branch and any federal agencies to act in
order to achieve their goals and policies, Congress must affirmatively authorize the funds required for these projects.47
In the case of mitochondrial replacement therapy, the FDA is the
federal agency seeking congressional appropriation of federal funding. The clinical use of mitochondrial replacement therapy in the
United States falls within the FDA’s regulatory authority because
the FDA’s oversight includes ensuring safe transfers of human cells
and tissues into human recipients.48 This includes the transfer of reproductive cells and tissues used in mitochondrial replacement therapy when mitochondria from a donor woman are transferred into the
cells of a woman at risk for passing along mitochondrial disease
traits. 49 Therefore, since Congress included provisions in Section
749 of the Consolidated Appropriations Act of 2016 that prohibit
45

“[T]he Constitution’s most significant check on Executive power: the President can spend funds on a program only if he can convince Congress to appropriate the money.” Kate Stith, Congress’ Power of the Purse, 97 YALE L.J. 1343,
1350 (1988) (emphasis added) (citation omitted). “Among the duties—and among
the rights, too—of this House, there is perhaps none so important as the control
which it constitutionally possesses over the public purse.” Id. (emphasis added)
(citation omitted).
46
U.S. CONST. art. I, § 9, cl. 7.
47
See Stith, supra note 45, at 1350.
48
Advisory, supra note 19. “The Food and Drug Administration’s (FDA)
Center for Biologics Evaluation and Research regulates an array of diverse and
complex biological products . . . including human cell and gene therapy products
and human cells and tissues. FDA’s oversight includes ensuring that human cells
and tissues intended for transfer into a human recipient, including reproductive
cells and tissues, are free from infectious diseases.” Id.
49
Id.
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the FDA from even accepting applications for clinical research involving gene editing in humans, clinical research of mitochondrial
replacement therapy in humans cannot legally proceed in the United
States at this time.50 This holds true even if the source of funding for
these experiments is from private third parties. The Consolidated
Appropriations Act of 2016 prohibits the use of any federal funds to
handle applications for the experiments.51 The FDA is “disabled”
from approving anyone to conduct experiments, even if they were
able to secure funding on their own.52
The appropriations requirement imposed on the executive
branch by the legislature is necessary because if Congress could not
prohibit federal agencies from withdrawing funds from the Treasury, the executive branch could essentially compel its own legislation by spending money at will in order to push its own policies.53
The Framers’ intent, according to James Madison, was to assure
that “the [legislature] alone ha[d] access to the pockets of the people.”54 What frustrates this issue even further, however, is that it has
never been seriously proposed or alleged that Congress would, or
even could, “violate” the Appropriations Clause by failing to effectively exercise control over federal expenditures.55 Notwithstanding

50

Id.
See Consolidated Appropriations Act, 2016, Pub. L. 114-113, § 749, 129
Stat. 2242, 2283 (2015).
52
See Achenbach, supra note 12 (“The omnibus fiscal 2016 budget bill
passed by Congress late last year contained language prohibiting the government
from using any funds to handle applications for experiments that genetically alter
human embryos.”). Dr. Shoukhrat Mitalipov described the function of the ban as
follows: “It seems like the FDA is disabled in this case by Congress . . . . At this
point we’re still not clear how to proceed.” Id. (emphasis added).
53
See Stith, supra note 45, at 1349.
54
Abner J. Mikva, Congress: The Purse, the Purpose, and the Power, 21 GA.
L. REV. 1, 3 (1986) (citing THE FEDERALIST No. 48, at 334 (James Madison) (J.
Cooke ed., 1961)).
55
Stith, supra note 45, at 1344–45. Stith discusses the general assumption by
constitutional scholars that “Congress has exclusive authority to construe and implement the appropriations clause,” yet no one has really ever “considered the
possibility that Congress itself may violate the clause.” Id. at 1345 n.5. But see
Dick Cheney et al., The Constitution and the Budget Process, in CONSTITUTIONAL
CONTROVERSIES 63, 95 (Robert A. Goldwin et al. eds., 1987) (suggesting that aspects of legislative budget practice are “not in keeping with . . . the spirit of the
appropriations clause”).
51
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the diverse interpretations of the intended effect of the Appropriations Clause, it remains concrete that, as used today, the appropriations power allows Congress to dictate exactly how federal agencies
allocate the amount of federal funding appropriated to them,56 even
in ways that are directly adverse to the executive branch or society
as a whole.
B. The Purpose of the Appropriations Power, as Intended by the
Framers of the Constitution
Based on the Framers’ placement of the Appropriations Clause
in Section 9 Article I, rather than in Section 8 with most other congressional powers and responsibilities, the appropriations requirement was arguably not meant to be a grant of affirmative power to
shape policy or push a partisan agenda.57 In practice, however, the
appropriations power does more than allocate funding to specified
agencies and projects. This power delineates the scope of congressionally authorized activities and forbids the progression of those
activities Congress opposes.58 Although this safeguard serves as a
valuable tool to protect abuses of power and discretion by the executive branch and federal agencies, it simultaneously allows the legislature to abuse its own power by essentially vetoing policies that
can greatly benefit society at large, such as mitochondrial replacement therapy.
The ideological premise behind Congress possessing sole authority to affirmatively dictate how all federal funds are allocated is
seemingly at odds with the separation of powers doctrine. Baron de
Montesquieu first popularized the doctrine of separation of powers
as the best strategy to avoid tyranny—the equal constitutional dis-

56
See Stith, supra note 45, at 1353 (“These strings, or conditions of expenditure, constitute legislative prescriptions that bind the operating arm of government. Occasionally, conditions may be stated in an appropriations statute itself.
For instance, an appropriations act may provide that ‘[n]o part of any appropriation contained in this Act shall be used . . . for publicity or propaganda purposes . . .’ Alternatively, the appropriations act may require that the recipient federal agency allocate the amount appropriated among certain activities or in accordance with certain conditions.” (emphasis added)).
57
See id. at 1349.
58
See id. at 1356.
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tribution of power among three branches of government: a legislative branch, executive branch, and judicial branch.59 Proponents of
the Constitution relied on Montesquieu’s theory in dividing the
power of government equally among the three branches in a way
best described by Abner J. Mikva: “Congress would manage the
purse, the President would wield the sword, and the courts would
exercise the power of review [to] protect individual liberties in the
newly formed federal government.”60 In other words, the individuals comprising each branch should have the “necessary constitutional means and personal motives to resist encroachment of the others.”61 In reality, however, how is the executive branch expected to
“wield its sword” effectively, if at all, if Congress is granted plenary
authority to dictate when and how it does so?
The answer lies in an interpretation of the Constitution that the
appropriations power was never meant to be used as a weapon that
allows Congress to affirmatively push its own policies. 62 If the
Framers truly intended the power of the purse to be the strongest and
most effective of all governmental powers, then it would also mean
that the Framers intended to give the legislative branch a significant
advantage over the executive branch in regards to checks and balances. 63 As pointed out earlier, however, James Madison’s works
show that the overarching goals of the Constitution were to ensure
that each branch possessed the necessary tools to prevent any encroachment or any one branch from being capable of overpowering

59

See Mikva, supra note 54, at 2.
Id.
61
Id. (quoting THE FEDERALIST NO. 51, at 349 (James Madison) (J. Cooke
ed., 1961)).
62
See Kate Stith, supra note 45, at 1348 (“While section 8 of article I enumerates the powers of the legislative branch, the appropriations clause in section
9 is not a grant of power. Rather, the appropriations clause affirmatively obligates
Congress to exercise a power already in its possession.”).
63
See Mikva, supra note 54, at 1–3. Mikva argues that, because the appropriations power is far and away the most powerful and effectual tool in the arsenal
of any of the three governmental branches, it must mean that the Framers of the
Constitution actually intended for the legislative branch to truly be the most powerful governing branch of the three. See id. This is obviously at odds with the
doctrine of separation of powers, but is a helpful argument in demonstrating just
how far the legislature is able to stretch the appropriations power to push their
own agenda.
60
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another.64 It may be inferred, then, that perhaps the appropriations
power has been abused in a way that makes the legislature more
powerful than the executive branch.
The discretionary power granted upon Congress to make budgetary decisions that shape social and fiscal policy is a necessary evil,
because, in theory, no branch is better suited to consider the diverse
interests of the people than the legislature elected by the people.65 In
order for this power to function properly and not run amuck with the
separation of powers doctrine, however, it can be inferred that Congress’ responsibility in appropriating funds to executive agencies
should be based on whether or not said appropriations will benefit
the people, not simply coincide with particular party lines.
C. How Has Congress Used the Appropriations Clause to Push
Policy in the Past?
Although Congress’ method of barring the FDA from reviewing
any further applications for mitochondrial replacement therapy can
be described as a questionable use of the appropriations power at
best, this is hardly the first time that Congress has used the Appropriations Clause to advance partisan objectives.66 In fact, Congress
effectively ended the Vietnam War simply through the exercise of
its appropriations power.67
In 1974 and 1975, once Congress had become convinced that the
Vietnam War needed to end, Congress refused to appropriate the
more than $500 million requested by President Gerald Ford to continue the war effort.68 Therefore, the war came to a rather abrupt end
because Congress’ denial to continue funding the war essentially

64

See id. at 2.
Id. at 4. Mikva believes that “[n]o institution is more willing–no institution
is better able–to consider and accommodate the[] [diverse interests of its citizens]
than the legislative branch. The Framers’ decision to give budgetary power to
Congress rested largely on this view.” Id.
66
Id. at 4–5.
67
Id. Mikva discusses that for years leading up to the Vietnam War and
throughout the war, Congress vehemently resisted the “costly and futile foreign
venture.” Id. at 4. Once Congress was completely convinced that the War had to
stop, it simply refused to appropriate any more money to the effort, forcing cessation against the executive branch’s wishes. Id. at 4–5.
68
Id.
65
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forced the cessation of hostilities. 69 In turn, the appropriations
power authorized Congress to not only make a determination that
the government cannot afford spending any more federal funds on a
particular activity—in this case, the controversial war—but it also
allowed Congress to make a determination that “the specified activity is no longer within the realm of authorized government actions.”70
Unlike the rejection of mitochondrial replacement therapy, Congress’ use of the appropriations power to end the Vietnam War is a
paradigm of how the Framers intended the power to be used.71 This
is vastly different than the situation surrounding mitochondrial replacement therapy. The Vietnam War represented an issue that divided the entire country72—an issue that resulted in the death of approximately 58,000 U.S. soldiers.73 Put another way, Congress’ decision to take action had much less to do with accommodating political ideologies than it did with resolving issues that had significant
detrimental impacts on many Americans.
In contrast, curing mitochondrial diseases that impact up to
4,000 children every year is hardly an issue dividing the people to
the extent that a Congressional ban seems prudent. Furthermore, if
the use of federal funds represented a financial issue, as opposed to
a social policy issue, Congress could have simply barred the use of
federal funds directly for research purposes but still allowed the
69

Id.
Stith, supra note 45, at 1360–61.
71
Mikva, supra note 54, at 4–5 (“The Framers’ decision to give budgetary
power to Congress rested largely on this view . . . . Clearly, the Framers believed
that decisions directly affecting the pocketbooks of our people should be made by
the governmental institution that is closest to them.”).
72
Stephen Zunes & Jesse Laird, The US Anti-Vietnam War Movement (19641973), INT’L CTR. ON NONVIOLENT CONFLICT (Jan. 2010), https://www.nonviolent-conflict.org/the-us-anti-vietnam-war-movement-1964-1973/ (“The U.S. war
in Vietnam triggered the most tenacious anti-war movement in U.S. history . . . .
[H]undreds of thousands of young people became radicalized in a largely nonviolent, diverse and sometimes inchoate popular culture of war resistance, employing tactics ranging from comical street theatre to industrial sabotage.”).
73
Vietnam War U.S. Military Fatal, Casualty Statistics, U.S. NAT’L ARCHIVES & RECORDS ADMIN. (Dec. 20, 2017), https://www.archives.gov/ research/military/vietnam-war/casualty-statistics.html (“The Vietnam Conflict Extract Data File of the Defense Casualty Analysis System (DCAS) Extract Files
contains records of 58,220 U.S. military fatal casualties of the Vietnam War.”).
70
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FDA to accept applications from clinical trials funded entirely by
third party payers. The fact that the appropriations requirement is
only a condition precedent to executive branch action supports the
notion that it was never intended to be a grant of affirmative power.
Instead, it was intended to be a limitation on the exercise of legislative power.74
III. AN AGE-OLD DEBATE: THE PARTISAN DIVIDE OVER
ABORTION AND THE TRANSITION TOWARDS EMBRYOS
A. Republican Opposition to Abortion
Ever since the Supreme Court decided in Roe v. Wade to grant
women a limited right to abortion,75 a “culture war” between Republicans and Democrats has raged regarding “the status of life after
conception and before birth.”76 Prior to Roe, abortion was criminalized by statute as homicide in some states. 77 Roe shifted the meaning
of the term “abortion” from a medical term used by physicians to a
“public and moral issue of nationwide concern” 78 that routinely
sparks contextual debates regarding human nature and when life
truly begins.79 I, like others, hypothesize that the divide amongst
74

Stith, supra note 45, at 1349–50, 1350 n.28 (“Placement of the appropriations requirement in section 9 is consistent . . . with the dual intent of the framers
both to limit the power of the executive branch and to restrain the federal government as a whole.”).
75
410 U.S. 113 (1973).
76
Janet L. Dolgin, Surrounding Embryos: Biology, Ideology, and Politics, 16
HEALTH MATRIX 27, 31 (2006) [hereinafter Dolgin, Surrounding Embryos]; see
Robin Toner, The Nation: To the Barricades; The Culture Wars, Part II, N.Y.
TIMES (Feb. 29, 2004), https://www.nytimes.com/2004/02/29/weekinreview/thenation-to-the-barricades-the-culture-wars-part-ii.html. At the 1992 Republican
National Convention, Patrick Buchanan referred to the “cultural war” for the “soul
of America” between Presidential candidates Bill Clinton and George H.W. Bush
centered around the ideological differences the two had on abortion. Toner, supra.
77
Kayhan Parsi, Metaphorical Imagination: The Moral and Legal Status of
Fetuses and Embryos, 2 DEPAUL J. HEALTH CARE L. 703, 716–17 (1999).
78
KRISTIN LUKER, ABORTION AND THE POLITICS OF MOTHERHOOD 127
(Brian Barry & Samuel L. Popkin eds., 1984) (emphasis omitted).
79
See id. at 158–91 (examining pro-life and pro-choice views); see also Dolgin, Surrounding Embryos, supra note 76, at 31 n.26 (“Luker reports that more
people became part of the movement opposing abortion in the year following Jan.
22, 1973 (the day on which Roe was decided) than in any other year before or
after.” (emphasis added)) (citing LUKER, supra note 78, at 137).
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party lines with regard to abortion is, or at least should be, identical
to a divide on the issue of mitochondrial replacement therapy because both involve the manipulation of embryos, and the disruption
of the natural fetal development process.80
Today more than ever, abortion remains a contentious issue that
diverges significantly depending on what side of the partisan line
one falls on.81 In a recent survey conducted by Pew Research Center, sixty-five percent (65%) of Republicans felt that abortion should
be illegal in all or at least most cases, while seventy-five percent
(75%) of Democrats felt that abortion should be legal in most
cases. 82 While pro-life advocates have often framed the divide over
abortion to stand for much larger social debates regarding “moral
values” and family structure,83 the thrust of most Republicans’ argument revolves around the personhood status of the fetus.84 Prolife advocates have long believed that fetuses and embryos deserve
better treatment than if they were biological property or tissue of the
mother because, although they are not “persons” in a strict legal
sense, they are in fact along a developmental path towards becoming
persons.85 Put simply, due to their “potential” for personhood, fetuses have always deserved a certain moral and intrinsic status as
being “part of the continuum of biological human life.”86 The strong
desire by pro-life advocates to restrict abortion, due to the personhood of a fetus, is summarized effectively in a metaphor by Dr. Steven Maynard-Moody, Director of the Institute for Policy & Social
Research at the University of Kansas as follows:
80

Corey Washington, Mitochondrial Replacement Therapies: Between Abortion and Genetic Engineering, SPARTAN IDEAS (June 3, 2014), http://spartanideas.msu.edu/2014/06/03/mitochondrial-replacement-therapies-between-abortion-and-genetic-engineering/.
81
Hannah Fingerhut, On Abortion, Persistent Divides Between – and Within
– the Two Parties, PEW RES. CTR. (July 7, 2017), http://www.pewresearch.org/
fact-tank/2017/07/07/on-abortion-persistent-divides-between-and-within-thetwo-parties-2/ (noting that “the partisan divide on abortion remains far more polarized than it was two decades ago”).
82
See id.
83
See Janet L. Dolgin, Embryonic Discourse: Abortion, Stem Cells, and
Cloning, 31 FLA. ST. U. L. REV. 101, 121–28 (2003) (discussing the broader social
implications that stem from the abortion debate).
84
See Dolgin, Surrounding Embryos, supra note 76, at 31–32.
85
See Parsi, supra note 77, at 704.
86
Id. at 705.
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[T]he fetus is not a spleen. Though wholly dependent
on the pregnant woman and unable to live outside her
womb, a not-yet-viable fetus is genetically distinct
from the pregnant woman; it is not an organ or tissue,
but a body, suggesting to some that it can be defined
as a person . . . . The view that the fetus is tissue or
tissue property is founded on complex scientific evidence about human development and legal arguments about torts and rights, whereas the image of
the fetus as a baby is based on a simple, emotional
reaction to the form: it looks like a baby.87
While the historical divide among partisan lines over abortion is
not the focal point of the potential divide over mitochondrial replacement therapy, it is important to understand this divide because
it represents the same partisan issue that has evolved as scientific
research has improved: the legal and moral status of embryos.
B. Republican Opposition to Embryonic and Stem-Cell Research
With scientific improvements in the medical industry allowing
us to see further and further down the line of fetal development,88
the politicization of the debate regarding the personhood of a fetus
began to evolve a similar politicization of the embryo.

87

STEVEN MAYNARD-MOODY, THE DILEMMA OF THE FETUS 86 (1995).
See Dolgin, Surrounding Embryos, supra note 76, at 34–35 (“Embryos
came into social consciousness as the result of medical and technological developments. The first among these developments was increasingly accurate and inexpensive pregnancy tests that could be used soon after conception, followed by
the development of ultrasonography which permitted pregnant women, their partners, and their health care providers to visualize the progress of a pregnancy before the start of the fetal stage. The appearance of an industry in infertility care in
the late 1970s and early 1980s played a major role in society’s reconceptulization
of the notion of embryo.”).
88
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When a male reproductive sperm cell fertilizes a female reproductive oocyte, or “egg,” a new cell is formed known as a “zygote.”89 When the zygote cell begins to divide, it becomes an “embryo.”90 The mass of cells that has formed after fertilization continues to be considered an “embryo” until approximately the eighth
week of development, at which point the embryo becomes a fetus.91
The fact that embryos are a cluster of cells—unlike fetuses,
which more closely resemble babies—has made it difficult for the
pro-life movement to muster the same strong argument for embryonic life as it could for fetal life.92 Despite this, many Republicans93
and other pro-life advocates such as the Catholic Church have
staunchly opposed any scientific research efforts that ultimately result in the manipulation or destruction of embryos.94
The partisan divide over the philosophical definition of embryos
is best highlighted by a juxtaposition of Democrat President Clinton’s proposed guidelines on federal funding for stem cell research
in 2000 with that of Republican President Bush’s opposition in
2005. Shortly after “U.S. scientists successfully isolated and cultured stem cells obtained from human embryos and fetuses” in 1998,
“President Clinton approved the National Institutes of Health’s
(NIH) proposed guidelines to allow federal funding for research on
stem cells.”95 This federal funding allowed scientists to study the
effects of introducing healthy stem cells into the body to potentially
treat many diseases that are caused from the death of dysfunctional

89

Egg to Embryo to Fetus: The Reproduction and Development Process, VISBODY, https://www.visiblebody.com/learn/reproductive/reproductive-process (last visited Sept. 20, 2018) [hereinafter Egg to Embryo to Fetus].
90
Id.; see also Simon Fishel, Assisted Conception in the Human – The Embryological View, in CONCEIVING THE EMBRYO: ETHICS, LAW, AND PRACTICE IN
HUMAN EMBRYOLOGY 15 (Donald Evans & Neil Pickering eds., 1996) (noting
that an embryo forms approximately twenty-four hours after fertilization).
91
Egg to Embryo to Fetus, supra note 89.
92
See Dolgin, Surrounding Embryos, supra note 76, at 35.
93
See infra text accompanying notes 98–106.
94
See Erin P. George, The Stem Cell Debate: The Legal, Political and Ethical
Issues Surrounding Federal Funding of Scientific Research on Human Embryos,
12 ALB. L.J. SCI. & TECH. 747, 751 (2002) (“The Catholic Church is opposed to
IVF because of the method used to collect semen, masturbation, and the fact that
sexual intercourse is not the procreative function used.”).
95
Id. at 748.
IBLE
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cells.96 In enthusiastic support of the emergence of stem cell capabilities, President Clinton commented that stem cell research offers
“potentially staggering benefits,” 97 and scientists worldwide have
commented on the potential benefits as well.98 However, opposition
to stem cell research often derives not from the potential benefits it
provides, but from the process required to get there.99 This process
requires human stem cells to be extracted from human embryos anywhere from seven to fourteen days after fertilization occurs,
thereby resulting in the death of the embryo.100
President Bush, on the other hand, strongly opposed all research
using human embryos, and sought to promptly end all federal funding of stem cell research.101 In 2005, after announcing that he intended to veto a pending bill that would allow federal funding for
embryonic stem-cell research,102 President Bush pledged to protect
those who he deemed “our society’s most vulnerable members.”103
Other prominent Republican figures have referred to proposed NIH
guidelines on stem cell research as “a sham” that “attempt to give a
glow of respectability to truly barbaric and grotesque experiments
on human beings.”104 As recently as July 2016, the Republican platform has explicitly opposed and condemned embryonic stem cell
research, announcing at the Republican Convention in July 2016:
We oppose embryonic stem cell research. We oppose
federal funding of embryonic stem cell research. We
96

See id. at 756.
Gretchen Vogel, NIH Allows Pluripotent Stem Cell Research, SCI. (Aug.
23, 2000, 6:00 PM), http://www.sciencemag.org/news/2000/08/nih-allows-pluri
potent-stem-cell-research [hereinafter Vogel, NIH].
98
See George, supra note 94, at 758.
99
See id. at 756.
100
See id.
101
See id. at 775.
102
See US Stem Cell Bill Stalls in Senate, BIONEWS (July 24, 2005), https://
www.bionews.org.uk/page_89755; see also Stem Cell Research Enhancement
Act of 2005, H.R. 810, 109th Cong. (2005).
103
Press Release, President George W. Bush, President Discusses Embryo
Adoption and Ethical Stem Cell Research (May 24, 2005), https://georgewbushwhitehouse.archives.gov/news/releases/2005/05/20050524-12.html.
104
Susan Lee, Harvard Law & Health Care Soc’y, Human Stem Cell Research: NIH Releases Draft Guidelines for Comment, 28 J.L. MED. & ETHICS 81,
82 (2000) (quoting Representative Christopher Smith, a Republican from New
Jersey) (emphasis added).
97
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support adult stem cell research and urge the restoration of the national placental stem cell bank created
by President George H.W. Bush but abolished by his
Democrat successor, President Bill Clinton. We oppose federal funding for harvesting embryos . . . .105
This statement sparked a response from Dr. George Q. Daley, a researcher at the Harvard Stem Cell Institute, who told Bloomberg
BNA that human embryonic stem cells are “essential” for medical
research, and that “[i]t would be a major setback should the Republican Party succeed in turning back the clock to a more restrictive
stem cell policy.”106
Even during the first debate of the 2016 Presidential campaign,
Republican candidates disagreed on every single topic discussed except for one: research using fetal tissue cells.107 Such a united front
against any and all research involving the use of donated embryos
represents a major hurdle for the scientific community towards improving health and saving lives, especially when bipartisan support
is needed to secure federal funding or approval. The latest experimental breakthrough to fall victim to Republican opposition: mitochondrial replacement therapy.
C. Why Opponents of Abortion and Embryo Research Are Likely
Opposed to Mitochondrial Replacement Therapy
Although virtually no literature currently discusses the division
over mitochondrial replacement therapy from a political ideology
standpoint, the similarities in mitochondrial replacement therapy research and stem cell research are clear. Therefore, the same partisan
group who has historically opposed abortion and various forms of

105
Republican Platform Blasts FDA, Seeks Embryonic Stem Cell Ban, RES.
AMERICA (July 20, 2016), http://www.researchamerica.org/news-events/news/
republican-platform-blasts-fda-seeks-embryonic-stem-cell-ban.
106
Id.
107
Dov Fox, The GOP Case Against Stem Cell Research, HUFFINGTON POST
(Aug. 7, 2015, 8:35 PM), https://www.huffingtonpost.com/dov-fox/gop-confusion-over-stem-c_b_7958424.html (“The [Republican candidates] disagreed on
every topic they faced—immigration, health care, foreign policy, gay rights, the
economy . . . . All 17 [candidates] in [the] debates . . . staunchly opposed research
that uses tissue cells from aborted or miscarried fetuses.” (emphasis added)).

322

UNIVERSITY OF MIAMI LAW REVIEW

[Vol. 73:300

embryonic research—the Republican Party—likely opposes mitochondrial replacement therapy experimentation as well. Because the
early experimental stages of mitochondrial replacement therapy in
human clinical trials would result in the destruction or discard of
donated embryos, Republicans and pro-life groups are likely to
equate the treatment of embryos in mitochondrial replacement therapy to the way embryos are destroyed during stem cell research.108
D. Progress Towards and Success of Mitochondrial Replacement
Therapy
Recent evidence from the United States indicates that mitochondrial replacement therapy techniques are in fact safe and effective in
primates. 109 However, further research is still necessary to determine both the safety and effectiveness in humans, as well as the
long-term effects of mitochondrial replacement therapy.110 In contrast, mitochondrial replacement therapy experimentation received
extensive support in the United Kingdom and, in 2015, the United
Kingdom Parliament voted to allow mitochondrial donation for the
purposes of mitochondrial replacement therapy on a case-by-case
basis.111 Further, in September 2016, the world’s first “three-parent
baby” was born after successful use of the mitochondrial replacement technique by a United States-based team in Mexico.112
Although concerns regarding safety and effectiveness inevitably
will remain, the successful application of the mitochondrial replacement therapy technique performed by Dr. John Zhang and his team
from New Hope Fertility Center in New York is likely to fast-forward progress from other nations more inclined to accept this research. 113 This successful application involved a patient of Dr.
108

See George, supra note 94, at 756.
See Orcutt, supra note 18.
110
UMDF Position & Clinical Status of Mitochondrial Replacement Therapy
to Prevent Transmission of mtDNA Disease, UNITED MITOCHONDRIAL DISEASE
FOUND. (Nov. 2017), http://www.umdf.org/mitochondrial-replacement-therapy/.
111
Id.
112
Jessica Hamzelou, Exclusive: World’s First Baby Born with New “3 Parent” Technique, NEW SCIENTIST (Sept. 27, 2016), https://www.newscientist.
com/article/2107219-exclusive-worlds-first-baby-born-with-new-3-parent-technique/.
113
See id. (“The controversial technique . . . has only been legally approved
in the UK. But the birth of the child, whose Jordanian parents were treated by a
109
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Zhang’s who carries a gene for Leigh Syndrome, which is a fatal
mitochondrial disorder that negates healthy development of the
nervous system.114 After Leigh Syndrome was passed down from
the mother’s mitochondrial DNA and killed their first two children,
the couple sought out Dr. Zhang and his team to perform a variation
of the mitochondrial replacement therapy known as “spindle nuclear
transfer.”115 Dr. Zhang was able to create five embryos for the couple, one of which developed normally, and was implanted in the
mother.116 Nine months later, the child was born healthy, with less
than one percent of his mitochondria carrying mutated mitochondrial DNA, far below the eighteen percent that is generally required
before problems begin to arise.117
Furthermore, Dr. Zhang’s approach was met with glowing remarks by colleagues in the field.118 Most importantly, the team executed the mitochondrial replacement therapy without destroying a
single embryo, and used only a male embryo so as to avoid any
chance a resulting female child could later pass on any inherited mitochondrial DNA.119 Dr. Sian Harding, Professor of Cardiac Pharmacology at the National Heart and Lung Institute,120 stated that Dr.
Zhang’s work was “as good or better than what we’ll do in the

US-based team in Mexico, should fast-forward progress around the world, says
embryologists.”).
114
Id.; see also Leigh Syndrome, U.S. NAT’L LIBRARY MEDICINE: GENETICS
HOME REFERENCE (June 2016), https://ghr.nlm.nih.gov/condition/leigh-syn
drome.
115
See Hamzelou, supra note 111. Hamzelou notes that because of the couple’s Muslim heritage, they were opposed to the destruction of what would be the
resulting embryos. Id. Therefore, Zhang performed spindle nuclear transfer,
whereby “[h]e removed the nucleus from one of the mother’s eggs and inserted it
into a donor egg that had had its own nucleus removed. The resulting egg – with
nuclear DNA from the mother and mitochondrial DNA from a donor – was then
fertilised with the father’s sperm.” Id.
116
Id.
117
Id.
118
See id. (“The team seems to have taken an ethical approach with their technique, says Sian Harding.”). Sian Harding is a Professor of Cardiac Pharmacology
at the National Heart and Lung Institute. Professor Sian Harding, IMPERIAL LONDON C., https://www.imperial.ac.uk/people/sian.harding (last visited Sept. 22,
2018).
119
Hamzelou, supra note 111.
120
Professor Sian Harding, supra note 117.
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UK.”121 It is a shame, however, that Dr. Zhang and his team had to
perform the procedure in Mexico, as opposed to New York, in order
to save this baby’s life.122
IV. CONGRESS ABUSED ITS APPROPRIATIONS POWER IN ORDER TO
PRECLUDE FURTHER RESEARCH ON
MITOCHONDRIAL REPLACEMENT THERAPY
While it is understandable that Republican and pro-life opposition towards embryonic research would result in hesitation to
quickly move forward from research in primates to research in humans, it was improper for Congress to bar clinical trials in the manner that it did. The preclusion of the FDA to review all public and
private applications for mitochondrial replacement therapy research
in an omnibus fiscal bill is a blatant misuse of the appropriations
power afforded to Congress. Not only does it prevent society from
receiving the large benefit the research would have, it also likely
violates the separation of powers doctrine by infringing on authority
that is rightfully afforded exclusively to the FDA.
A. The Context Behind How the Ban Was Introduced Is Controversial and Concerning
As argued previously, the Framers’ intent in granting the appropriations power to the legislative branch was to give Congress no
more authority than necessary to manage123 the “purse” that is the
federal treasury.124 Although wielding wide discretion to appropriate, Congress’ power was intended to be limited to the extent necessary to prevent abuses in spending by the executive branch and its
agencies.125 This was meant to serve as a guard against encroachment by the executive branch, not an affirmative weapon to controvert the executive branch.126

121

Hamzelou, supra note 111.
See id. (“Neither method has been approved in the US, so Zhang went to
Mexico instead, where he says ‘there are no rules[.’] He is adamant that he made
the right choice. ‘To save lives is the ethical thing to do,’ he says.”).
123
See Mikva, supra note 54, at 2.
124
See supra Sections II.A., II.B.
125
See id.
126
See id.
122
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The circumstances surrounding the ban encompassing mitochondrial replacement therapy are nothing short of suspicious. Congressional Republicans proposed the $1.1 trillion omnibus spending
bill in a fashion that forced President Obama to sign the bill with
little time to review because he faced the prospect of a complete
government shut down.127 The bill, which was over 2,000 pages in
length,128 contained a vast range of other appropriations that needed
to be voted on in an “all-or-nothing”129 fashion as part of the annual
balancing of the federal budget process. Tucked away discreetly in
a ten-line provision amidst this massive federal spending bill is the
language that affirmatively preempts the FDA from evaluating mitochondrial replacement therapy research.130 The congressional record is completely silent regarding the identities of the sponsors of
the ban, as well as the precise motives for sneaking it into the bill in
such a manner.131 There was a “complete absence of discussion before its passage or at any time thereafter,” despite being included “in
a must-pass omnibus appropriation bill.” 132 Dr. Eli Adashi has said
that scientists and other advocates of the research have “no idea how
the ban’s language even came to be a part of the bill” and that
“[t]here’s no paper trail, there’s no smoking gun—there is just the

127

Tanya Lewis, Congress Just Put a Massive Roadblock in the Way of Genetically Editing Human Embryos, BUS. INSIDER (Dec. 16, 2015, 2:45 PM),
http://www.businessinsider.com/congress-bans-funding-for-embryo-gene-editing-2015-12.
128
The bill contains 2,009 pages worth of appropriations and conditions. See
generally H.R. RULES COMM., 114TH CONG., TEXT OF HOUSE AMENDMENT #1 TO
THE SENATE AMENDMENT TO H.R. 2029, MILITARY CONSTRUCTION AND VETERANS AFFAIRS AND RELATED AGENCIES APPROPRIATIONS ACT, 2016 (Comm.
Print. 2015).
129
See id.; see also Lewis, supra note 126 (“[T]he spending bill also expands
the National Institutes of Health’s annual budget by $2 billion to a total of $32
billion, including $350 million for Alzheimer’s research. In addition, the Food
and Drug Administration will get an additional $133 million for a total of $2.7
billion, which includes additional funding for President Obama’s Precision Medicine Initiative.”).
130
See Consolidated Appropriations Act, 2016, Pub. L. 114-113, § 749, 129
Stat. 2242, 2283 (2015).
131
Adashi & Cohen, supra note 9, at 575.
132
Id.
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result.”133 Even the Appropriations Committee spokesperson, Jennifer Hing, refused to comment on where the language came from
when pressed on the issue by BuzzFeed in 2016.134
This series of events does not represent a legislative “check” on
the executive branch’s “wielding of its sword,” as Baron de Montesquieu and James Madison intended in framing the separation of
powers doctrine and the Constitution.135 The FDA has served as a
consumer protection agency since the congressional passage of the
1906 Pure Food and Drugs Act,136 and possesses plenary authority
to ensure that food, cosmetics, drugs and medical devices are medically and nutritionally sound. 137 By definition, the appropriations
power does not explicitly grant the legislative branch authority to
dictate how executive agencies enforce the law, yet that is seemingly
what the condition attached to Section 749 of the Consolidated Appropriations Act of 2016 aimed to do by outlawing any reviews of
applications for particular medical research.138 Congress is authorized by the Constitution to deny appropriations, and quite frankly,
should be encouraged to if federal funds are sought in an encroaching manner or for a particular activity that does not serve the best
interests of the people. Reviewing clinical applications for privately
funded medical research that can save thousands of lives every year,
however, does not match that description.
B. The Congressional Ban Was Just as Careless
as It Was Purposeful
There is no denying that the language of Section 749 of the Consolidated Appropriations Act of 2016, which prohibits the FDA
from reviewing applications “in which a human embryo is intention-
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ally created or modified to include a heritable genetic modification”139 grounds any further research on mitochondrial replacement
therapy in the United States for the time being. However, what if
mitochondrial replacement therapy was not the intended target of
the Republican Congress’ misuse of the Appropriations Clause? Is
careless crafting of a budget bill that handcuffs the FDA’s administrative authority to regulate an area of scientific research any less
damaging than a purposeful and sneaky effort to tuck such a divided
and controversial provision into a colossal omnibus bill without any
explanation for its inclusion?
Some experts in the field, such as Dr. Eli Adashi, believe that
there is a strong likelihood that Congress’ primary target was not, in
fact, mitochondrial replacement therapy, but a more controversial
genetic technology known as “CRISPR.”140 CRISPR technology is
much more in line with the traditional fears held by Republicans and
pro-life advocates that scientists will try and “play God”141 by engineering “designer babies” through the direct manipulation of the human genomes.142 CRISPR is significantly more controversial than
mitochondrial replacement therapy because rather than swapping
out already existing DNA with DNA from another person in order
to prevent the passage of a disease, “CRISPR targets specific genes
in the code to delete or ‘edit,’” thus leading to the fear of future “designer babies.”143
This contentious technology possesses the sort of social and ethical concerns that the Framers likely would have had in mind when
giving the legislative branch authority to deny appropriations to executive agencies. Yet, the perhaps unintended consequence of the
139

Id.
See Subbaraman, supra note 6.
141
Loike & Reame, supra note 29.
142
See Subbaraman, supra note 6; see also Questions and Answers About
CRISPR, BROAD INST., https://www.broadinstitute.org/what-broad/areas-focus/
project-spotlight/questions-and-answers-about-crispr (last visited Sept. 19, 2018)
(“‘CRISPR’ (pronounced ‘crisper’) stands for Clustered Regularly Interspaced
Short Palindromic Repeats, which are the hallmark of a bacterial defense system
that forms the basis for CRISPR-Cas9 genome editing technology. In the field of
genome engineering, the term ‘CRISPR’ or ‘CRISPR-Cas9’ is often used loosely
to refer to the various CRISPR-Cas9 and -CPF1, (and other) systems that can be
programmed to target specific stretches of genetic code and to edit DNA at precise
locations, as well as for other purposes, such as for new diagnostic tools.”).
143
See Subbaraman, supra note 6.
140

328

UNIVERSITY OF MIAMI LAW REVIEW

[Vol. 73:300

way in which Congress drafted the budget bill in 2016 precluded not
only CRISPR, but other areas of genetic research that do not pose
vast ethical dilemmas and partisan divisions. It was very feasible at
the time the bill was passed for the drafters of the bill to deny appropriations for FDA review of applications for CRISPR research,
without simultaneously precluding mitochondrial replacement therapy research in the process.
Even if Congress’ outright ban on genetic modification research
on human embryos was aimed at CRISPR with good intentions, it
was clearly ineffective and, quite frankly, unnecessary. Many scientists today are in agreement that testing CRISPR germline editing in
humans is nothing short of ethically impermissible and “irresponsible at this point.”144 Furthermore, a global committee consisting of
gene-editing experts and ethicists, which convened at the International Summit on Human Gene Editing in 2015 concluded that creating gene-modifications in humans cannot go forward until the
safety is established and there is a “broad social consensus on
whether such a step is desirable.”145 David Baltimore, a Nobel Prizewinning biologist at the California Institute of Technology, stated
that “[t]he human genome is shared among all nations . . . . [Safety
and social/ethical consensus] criteria have not been met for any proposed clinical use.”146
If CRISPR was the target of the language in the bill, it was superfluous for Congress to seek to bar any research efforts of this type
when the scientific community is seemingly in agreement that it is
unsafe and unethical to further research efforts in the first place.
Moreover, the way in which Congress chose to attack CRISPR was
also imprudent and reckless because it barred further research on
mitochondrial replacement therapy. Whether Congress purposefully
targeted mitochondrial replacement therapy based on partisan viewpoints towards personhood and embryonic research or whether mitochondrial replacement therapy was an unintended casualty of an
intended ban on CRISPR does not change the fact that Congress
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abused its appropriations power in the process. Regardless of Congress’ true intent, Congress did not trigger its appropriations power
to prevent the executive branch from spending money at will and
pushing its own policies and agenda, as the Framers originally intended the power to be used. Instead, Congress affirmatively barred
a federal agency from reviewing applications for privately funded
research that is safe, ethically permissible, and has the potential to
help save thousands of lives.
V. FUTURE RECOURSE AND THE RECOMMENDED NEXT STEPS FOR
THE FDA
As pointed out in Part I, to date, there has been no judicial enforcement of the Constitution’s appropriations requirement against
Congress itself,147 and it is therefore unclear if and how Congress
can even be found in violation of Article I, Section 9.148 In fact, any
judicial challenge to the spending authority of Congress is likely
doomed based on the Supreme Court’s indication that “Congress has
absolute authority to construe and to effectuate the appropriations
requirement.”149 While it is relatively clear that the executive branch
violates the Appropriations Clause if it spends funds not appropriated by Congress or based on Congress’ limitations, it is not entirely
clear how Congress can be said to “violate” the Appropriations
Clause. Such a violation would likely arise by legislating openended spending authority in areas in which the executive branch
bears substantial discretionary power.150
A judicial challenge to the congressional ban on gene editing
research involving human embryos is almost guaranteed to fail,
based on the historical context in which the appropriations power
has been construed.151 In United States v. Richardson, the Supreme
Court held that Congress has “plenary” authority to implement the
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very similar “Statement and Account” clause involving appropriations for the CIA.152 In Harrington v. Bush, a congressman’s challenge alleging that the CIA was using its secret appropriations for
unauthorized activities was dismissed for lack of standing,153 but not
before the Court suggested that Congress has “plenary” authority to
interpret Article I, Section 9, “including the appropriations clause,
and that the courts therefore have no power to consider the constitutional adequacy of spending legislation.”154 Clearly, the Court has
decided that the judicial branch is not positioned or constitutionally
capable of definitively determining what role independent executive
agencies should have in developing the federal budget.
This predicament does not foreclose the motive or opportunity
the FDA, and others in the field, should have to lobby Congress for
a much more specific bill that would allow mitochondrial replacement therapy research to go forward with caution. Although the allencompassing language used in Section 749 of the Consolidated Appropriations Act of 2016 includes technologies like mitochondrial
replacement therapy and CRISPR based on strict interpretation of
the terminology used, the bill does not specifically ban “mitochondrial replacement therapy” or “CRISPR” by name.155 Due to the fact
that mitochondrial replacement therapy is only used to prevent the
passage of heritable deadly mitochondrial diseases,156 as well as the
relative progress that has been demonstrated by research in other
countries thus far,157 it is not farfetched to suggest that Congress
152
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may be receptive to legislation that creates a narrow, specific exception to Section 749 of the Consolidated Appropriations Act for mitochondrial replacement therapy research.
As far as lobbying Congress for reconsideration of the ban
against mitochondrial replacement therapy goes, the most effective
recommendation the FDA could offer as a starting point likely
comes in the same form as the original recommendation the expert
panel from the National Academies of Sciences made to the FDA in
2016 before the congressional ban was unveiled.158 This proposal
would effectively address the ethical, social, and political issues surrounding mitochondrial replacement therapy in a way that may convince even a Republican Congress to allow preliminary clinical trials to proceed.
First, the panel recommended that federal regulation be implemented, along with principled professional society guidelines to interpret said regulations, to limit any use of mitochondrial replacement therapy strictly to the prevention of life-threatening mitochondrial diseases.159 This safeguard would assure that research is conducted for the prevention of disease, and would help convince those
that misconstrue this technology as analogous with other gene-editing techniques like CRISPR, that this research would not ultimately
lead to the ethical melting pot that is “designer babies.”
Second, despite the inevitable ethical, social, and political debates associated with research that involves the manipulation and
destruction of donated embryos, responsible use of said embryos in
clinical research of mitochondrial replacement therapy through ethical frameworks that have already been developed would give atrisk women an opportunity to have genetically related children with
a significantly reduced risk of that child having mitochondrial diseases. 160 Despite the unavoidable divide among many people regarding the use of donated human embryos for clinical research, it
speaks volumes that a diverse panel of experts in both science and
ethics have concluded that at this point it is “ethically permissible to
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conduct clinical investigations of [mitochondrial replacement therapy] subject to certain conditions and principles.”161
Lastly, the “slow, cautious approach,” recommended by the expert committee from the Institute of Medicine and outlined below,
is the most reasonable way to address the “ethical, social, and political concerns” many critics of mitochondrial replacement therapy
share.162 Specifically, the aforementioned expert committee maintains that the FDA should begin to consider mitochondrial replacement therapy clinical applications only when all health and safety
risks are minimized, and the “[l]ikelihood of efficacy is established
by preclinical research using in vitro modeling, animal testing, and
testing on human embryos as necessary.” 163 Furthermore, these
clinical studies should be limited exclusively to women who are
“undisputed[ly]” at risk for transmitting “severe” mitochondrial diseases “characterized by early mortality or substantial impairment of
basic function.”164 Additionally, the expert committee proposes limiting initial testing to the gestational transfer of male embryos “to
prevent potential adverse and uncertain consequences of mitochondrial replacement therapy from being passed on to future generations” via female offspring.165 Lastly, in order to uphold ethical principles and medical standards, all initial clinical applications should
be reserved exclusively to researchers with “demonstrated expertise
in and skill with relevant techniques.”166
CONCLUSION
Regardless of what side of the line one falls on when defining
the personhood of an embryo, the ethics of embryonic donation and
research, or the future of genetic manipulation and engineering,
there is no denying that Congress’ premature decision to take a firm
stance on these matters through Section 749 of the Consolidated Appropriations Act of 2016 precluded thousands of helpless families
161
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from pursuing what could turn out to be life-saving technology for
their future children. Rather than stand firmly in the sand on what
has historically been the Republican ideology towards life and personhood in regards to fetuses and embryos by directly legislating on
the matter, Congress controversially and strategically tucked this
ban away ever so subtly in a colossal financial bill without leaving
any trace as to who actually introduced the ban, or why.
This blatant exercise of partisanship and policy implementation
is directly adverse to the purpose of the Appropriations Clause as
envisioned by the Framers—a passive check necessary to prevent
encroachment on Congress’ management of the purse by the executive branch. “Management” of the purse, however, should not be
synonymous with complete dictation over the executive branch’s
ability to use the purse to carry out its own policies and responsibilities. Such tolerance of complete and utter legislative control is a
flagrant violation of the separation of powers doctrine that can and
will stall progress in a variety of ways. Mitochondrial replacement
therapy can prevent thousands of women in the United States from
passing along fatal heritable mitochondrial diseases to their children. For now these women are forced to travel to foreign countries
to seek any form of medical recourse. This is because, instead of
coming to an agreement over the obvious benefits that mitochondrial replacement therapy provides, Republicans and Democrats
alike harp over the divergent philosophies towards the research required to get to the finish line.

